Document Detail

Glucagon as a treatment of severe hypoglycemia: safe and efficacious but underutilized.
MedLine Citation:
PMID:  18267999     Owner:  NLM     Status:  MEDLINE    
Over the past 2 decades, a number of different studies have demonstrated that tight metabolic control not only reduces the incidence but also delays the development of complications in people with type 1 and type 2 diabetes. Unfortunately, the intensive insulin therapy required to achieve tight glucose control is also associated with a significantly increased risk of developing hypoglycemia. Hypoglycemia can cause physical as well as psychosocial morbidity, has been associated with adverse neurological manifestations, and can sometimes result in death. It can affect daily activities such as driving, working, and studying and can result in inconvenience and embarrassment as well as cause fear for both the person with diabetes and significant others. This fear is often the biggest barrier for optimal glycemic control. With self-management education and regular monitoring of blood glucose, people with diabetes can learn to recognize their unique signs and symptoms of hypoglycemia, and with improved understanding of how insulin, food, and activity affect blood glucose levels, the patient can learn to prevent hypoglycemia. However, because managing blood glucose can be such a delicate balancing act, it is important to be prepared. An important weapon in the treatment of severe hypoglycemia is the use of glucagon, a treatment that is generally underappreciated, underevaluated, undertaught, and most certainly underutilized. The purpose of this article is to review the role of glucagon in the treatment of severe hypoglycemia and discuss how better information about and understanding of the use of glucagon might be helpful toward alleviating some of the fears surrounding hypoglycemia.
Teresa Pearson
Related Documents :
6391719 - Persistent hyperinsulinemia due to induced euglycemia in awake endotoxic minipigs.
17510699 - Type 1 diabetes: exercise and hypoglycemia.
2166699 - Differential effects of human and pork insulin-induced hypoglycemia on neuronal functio...
1799919 - Comparison of the counterregulatory hormone response to semisynthetic human insulin and...
1020609 - Acute self-poisoning with phenformin.
18500459 - A case of systemic lupus erythematosus presenting as hypoglycemia due to anti-insulin r...
8335169 - Tolbutamide reduces the incidence of diabetes mellitus, but not insulitis, in the non-o...
24931609 - Nucks is a positive transcriptional regulator of insulin signaling.
16224939 - Current evidence regarding the value of self-monitored blood glucose testing.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Diabetes educator     Volume:  34     ISSN:  0145-7217     ISO Abbreviation:  Diabetes Educ     Publication Date:    2008 Jan-Feb
Date Detail:
Created Date:  2008-02-12     Completed Date:  2008-04-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7701401     Medline TA:  Diabetes Educ     Country:  United States    
Other Details:
Languages:  eng     Pagination:  128-34     Citation Subset:  N    
Fairview Health Services, Minneapolis, MN 55436, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Glucose / drug effects,  metabolism
Diabetes Mellitus, Type 1 / blood
Diabetes Mellitus, Type 2 / blood
Gastrointestinal Agents / therapeutic use*
Glucagon / pharmacokinetics,  therapeutic use*
Hypoglycemia / drug therapy*,  epidemiology,  physiopathology
Reg. No./Substance:
0/Blood Glucose; 0/Gastrointestinal Agents; 9007-92-5/Glucagon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Efficacy of meal replacements versus a standard food-based diet for weight loss in type 2 diabetes: ...
Next Document:  Optimizing diabetes treatment using an amylin analogue.